The medical imaging and therapeutic technologies that are based on the use of radiation
are reviewed briefly, with special emphasis on the recent developments of synchrotron …

First characterized in 1982, the genetic absence epilepsy rat from Strasbourg (GAERS) has
emerged as an animal model highly reminiscent of a specific form of idiopathic generalized …

Radiotherapeutic doses for malignant gliomas are generally palliative because greater,
supposedly curative doses would impart clinically unacceptable damage to nearby vital …

Microbeam radiation therapy (MRT) uses highly collimated, quasi-parallel arrays of X-ray
microbeams of 50–600keV, produced by third generation synchrotron sources, such as the …

Aim Viviparity has evolved more times in squamates than in any other vertebrate group;
therefore, squamates offer an excellent model system in which to study the patterns, drivers …

Studies have shown that x-rays delivered as arrays of parallel microplanar beams
(microbeams), 25-to 90-μm thick and spaced 100–300 μm on-center, respectively, spare …

Purpose: This Monte Carlo simulation work aims at studying a new radiotherapy approach
called proton‐minibeam radiation therapy (pMBRT). The main objective of this proof of …

Synchrotron facilities produce ultra-high dose rate X-rays that can be used for selective
cancer treatment when combined with micron-sized beams. Synchrotron microbeam …

Microbeam radiation therapy (MRT), a novel form of spatially fractionated radiotherapy (RT),
uses arrays of synchrotron-generated X-ray microbeams (MB). MRT has been identified as a …

PURPOSE: High-dose synchrotron microbeam radiation therapy (MRT) can be effective at
destroying tumors in animal models while causing very little damage to normal tissues. The …